KCNJ13 Gene Deletion Impairs Cell Alignment and Phagocytosis in Retinal Pigment Epithelium Derived from Human-Induced Pluripotent Stem Cells.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
11 05 2020
Historique:
entrez: 22 5 2020
pubmed: 22 5 2020
medline: 29 9 2020
Statut: ppublish

Résumé

The purpose of this study was to establish and analyze a cell model of Leber congenital amaurosis type 16 (LCA16), which is caused by mutations in the KCNJ13 gene encoding Kir7.1, an inward-rectifying potassium ion channel. The two guide RNAs specific to the target sites in the KCNJ13 gene were designed and KCNJ13 knock-out (KO) human-induced pluripotent stem cells (hiPSCs) were generated using the CRISPR/Cas9 system. The KCNJ13-KO hiPSCs were differentiated into retinal pigment epithelial cells (hiPSC-RPEs). The KCNJ13-KO in hiPSC-RPEs was confirmed by immunostaining. Phagocytic activity of hiPSC-RPEs was assessed using the uptake of fluorescently labeled porcine photoreceptor outer segments (POSs). Phagocytosis-related genes in RPE cells were assessed by quantitative polymerase chain reaction. Most of the translated region of the KCNJ13 gene was deleted in the KCNJ13-KO hiPSCs by the CRISPR/Cas9 system, and this confirmed that the Kir7.1 protein was not present in RPE cells induced from the hiPSCs. Expression of RPE marker genes such as BEST1 and CRALBP was retained in the wild-type (WT) and in the KCNJ13-KO hiPSC-RPE cells. However, phagocytic activity and expression of phagocytosis-related genes in the KCNJ13-null hiPSC-RPE cells were significantly reduced compared to those of WT. We succeeded in generating an RPE model of LCA16 using hiPSCs. We suggest that Kir7.1 is required for phagocytosis of POSs by RPE cells and that impaired phagocytosis in the absence of Kir7.1 would be involved in the retinal degeneration found in LCA16.

Identifiants

pubmed: 32437550
pii: 2766230
doi: 10.1167/iovs.61.5.38
pmc: PMC7405706
doi:

Substances chimiques

KCNJ13 protein, human 0
Potassium Channels, Inwardly Rectifying 0
CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38

Références

Sci Rep. 2015 Feb 10;5:8366
pubmed: 25666713
Curr Eye Res. 2003 Nov;27(5):279-87
pubmed: 14562164
Elife. 2014 Sep 29;3:
pubmed: 25265470
Bioinformatics. 2015 Apr 1;31(7):1120-3
pubmed: 25414360
J Biol Chem. 2011 May 6;286(18):16030-8
pubmed: 21402702
Physiol Rev. 2010 Jan;90(1):291-366
pubmed: 20086079
J Physiol. 2001 Feb 15;531(Pt 1):27-36
pubmed: 11179389
Exp Eye Res. 2018 Nov;176:219-226
pubmed: 30009826
J Exp Med. 2004 Dec 20;200(12):1539-45
pubmed: 15596525
Nat Protoc. 2016 Nov;11(11):2154-2169
pubmed: 27711053
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3178-85
pubmed: 12824269
J Vis Exp. 2014 Dec 12;(94):
pubmed: 25548986
Hum Mutat. 2015 Jul;36(7):720-7
pubmed: 25921210
Mol Vis. 2011;17:1485-92
pubmed: 21677792
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4847-4855
pubmed: 28973331
PLoS One. 2017 Jul 18;12(7):e0181481
pubmed: 28719670
Retin Cases Brief Rep. 2017 Summer;11(3):221-226
pubmed: 27203561
Sci Rep. 2018 Jan 11;8(1):461
pubmed: 29323137
J Cell Biol. 1971 Jun;49(3):664-82
pubmed: 5092207
J Biol Chem. 2002 May 10;277(19):17016-22
pubmed: 11861639
Free Radic Res. 2019 Feb;53(2):226-236
pubmed: 30741054
Sci Rep. 2017 Sep 6;7(1):10651
pubmed: 28878288
Invest Ophthalmol Vis Sci. 1978 Feb;17(2):105-16
pubmed: 624604
Am J Hum Genet. 2011 Jul 15;89(1):183-90
pubmed: 21763485
Exp Eye Res. 2014 Sep;126:51-60
pubmed: 24780752
Channels (Austin). 2014;8(6):488-95
pubmed: 25558901
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):826-38
pubmed: 12556419
Stem Cell Reports. 2014 Jan 23;2(2):205-18
pubmed: 24527394
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2389-2394
pubmed: 28193887
Mol Vis. 2010 Mar 09;16:369-77
pubmed: 20300561
Cell. 2015 Aug 27;162(5):1101-12
pubmed: 26317472
Exp Eye Res. 2008 Sep;87(3):176-83
pubmed: 18653180
Stem Cell Reports. 2017 Jul 11;9(1):42-49
pubmed: 28625537
Br J Ophthalmol. 2010 Aug;94(8):1094-9
pubmed: 20538656
Neuron. 2012 Dec 20;76(6):1123-32
pubmed: 23259948
Am J Hum Genet. 2019 Feb 7;104(2):310-318
pubmed: 30686507
Stem Cell Reports. 2015 Jan 13;4(1):143-154
pubmed: 25434822

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH